Robert Lorne Hopfner, Director at Vaxcyte, Inc. (PCVX), sold 164,675 shares at $25.42 ($4.3M) on 2021-01-11, disclosed to the SEC on 2021-01-13.
Open-market sale of $4.3M PCVX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.42 | 12,480 | $317K | 7.3% |
| 2 | $25.42 | 12,480 | $317K | 7.3% |
| 3 | $26.69 | 24,980 | $667K | 15.4% |
| 4 | $26.69 | 24,980 | $667K | 15.4% |
| 5 | $27.02 | 12,206 | $330K | 7.6% |
| 6 | $27.02 | 12,206 |
| $330K |
| 7.6% |
| 7 | $26.35 | 17,666 | $465K | 10.7% |
| 8 | $26.35 | 17,666 | $465K | 10.7% |
| 9 | $27.05 | 901 | $24K | 0.6% |
| 10 | $25.90 | 26,010 | $674K | 15.5% |
| 11 | $26.34 | 3,100 | $82K | 1.9% |
| Total | $26.34 avg | 164,675 | $4.3M | 100% |
| Filing → |
| INZY | BUY | 2023-05-15 | $5.7M | — | Filing → |
| INZY | BUY | 2023-03-30 | $3.1M | — | Filing → |
| INZY | BUY | 2023-03-29 | $1.7M | — | Filing → |